Trademark: 88317134
Status Date
Tuesday, November 19, 2019
Registration Number
5916753
Registration Date
Tuesday, November 19, 2019
Filing Date
Tuesday, February 26, 2019
Published for Opposition
Tuesday, June 25, 2019
5 Pharmaceutical preparations for use in immunotherapy; tumor suppressing agents; pharmaceutical products for the treatment of cancer and tumors; pharmaceuticals, namely, immunogenic cell death inducers; therapeutic agents for promotion of cancer immunity
The English translation of the word "NAMMI" in the mark is "candy".
"THERAPEUTICS"
Mar 31, 2021
Automatic Update Of Assignment Of Ownership
Mar 3, 2021
Automatic Update Of Assignment Of Ownership
Nov 19, 2019
Registered-Principal Register
Oct 12, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 11, 2019
Allowed Principal Register - Sou Accepted
Oct 7, 2019
Statement Of Use Processing Complete
Sep 17, 2019
Use Amendment Filed
Oct 7, 2019
Case Assigned To Intent To Use Paralegal
Sep 17, 2019
Teas Statement Of Use Received
Aug 20, 2019
Noa E-Mailed - Sou Required From Applicant
Jun 25, 2019
Official Gazette Publication Confirmation E-Mailed
Jun 25, 2019
Published For Opposition
Jun 5, 2019
Notification Of Notice Of Publication E-Mailed
May 20, 2019
Assigned To Lie
May 7, 2019
Approved For Pub - Principal Register
May 7, 2019
Examiner's Amendment Entered
May 7, 2019
Notification Of Examiners Amendment E-Mailed
May 7, 2019
Examiners Amendment E-Mailed
May 7, 2019
Examiners Amendment -Written
May 7, 2019
Assigned To Examiner
Mar 18, 2019
New Application Office Supplied Data Entered
Mar 1, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
